BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2866128)

  • 1. The effect of met-enkephalin and naloxone on somatostatin and insulin secretion from the isolated, perfused rat pancreas.
    Di Scala-Guénot D; McIntosh CH
    Diabetes; 1985 Dec; 34(12):1283-7. PubMed ID: 2866128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enkephalins and the secretion of pancreatic somatostatin and insulin in the dog: studies in vitro.
    Hermansen K
    Endocrinology; 1983 Sep; 113(3):1149-54. PubMed ID: 6135603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of enkephalins and morphine on insulin secretion from isolated rat islets.
    Green IC; Perrin D; Pedley KC; Leslie RD; Pyke DA
    Diabetologia; 1980 Aug; 19(2):158-61. PubMed ID: 6998819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of beta-endorphin, met-enkephalin, and dynorphin A on basal and stimulated insulin secretion in the mouse.
    Ahrén B
    Int J Pancreatol; 1989 Sep; 5(2):165-78. PubMed ID: 2574736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose stimulation of somatostatin and insulin release from the isolated, perfused rat pancreas.
    Sorenson RL; Lindell DV; Elde RP
    Diabetes; 1980 Sep; 29(9):747-51. PubMed ID: 6108275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of mu- and delta-receptors in rat pancreatic islets for the opioid-mediated insulin release.
    Verspohl EJ; Berger U; Ammon HP
    Biochim Biophys Acta; 1986 Sep; 888(2):217-24. PubMed ID: 2874836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid peptide effects on insulin release and c-AMP in islets of Langerhans.
    Green IC; Ray K; Perrin D
    Horm Metab Res; 1983 Mar; 15(3):124-8. PubMed ID: 6133828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dynorphin on insulin and somatostatin secretion, calcium uptake, and c-AMP levels in isolated rat islets of Langerhans.
    Green IC; Perrin D; Penman E; Yaseen A; Ray K; Howell SL
    Diabetes; 1983 Aug; 32(8):685-90. PubMed ID: 6135634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enkephalinergic control of somatostatin secretion from the perfused rat stomach.
    McIntosh CH; Kwok YN; Mordhorst T; Nishimura E; Pederson RA; Brown JC
    Can J Physiol Pharmacol; 1983 Jul; 61(7):657-63. PubMed ID: 6137272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of growth hormone-releasing factor (GRF) on secretion of insulin, glucagon and somatostatin from perfused rat pancreas].
    Kawagishi T
    Nihon Naibunpi Gakkai Zasshi; 1990 May; 66(5):557-71. PubMed ID: 1974524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E1: stimulation of somatostatin and insulin responses to glucose from the isolated perfused rat pancreas.
    Nishi S; Seino Y; Seino S; Tsuda K; Takemura J; Ishida H; Imura H
    Prostaglandins Leukot Med; 1982 Jun; 8(6):593-7. PubMed ID: 6125951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas.
    Qader SS; Håkanson R; Rehfeld JF; Lundquist I; Salehi A
    Regul Pept; 2008 Feb; 146(1-3):230-7. PubMed ID: 17942170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEK inhibits secretin release and pancreatic secretion: roles of secretin-releasing peptide and somatostatin.
    Li JP; Lee KY; Chang TM; Chey WY
    Am J Physiol Gastrointest Liver Physiol; 2001 May; 280(5):G890-6. PubMed ID: 11292597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of PHI on hormonal secretion from perfused rat pancreas.
    Szecówka J; Tendler D; Efendić S
    Am J Physiol; 1983 Oct; 245(4):E313-7. PubMed ID: 6137956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory actions of a somatostatin analog SMS 201-995 on endocrine secretion from the isolated perfused stomach and pancreas of the rat.
    Verchere CB; Kwok YN; Brown JC
    Pharmacology; 1993; 46(1):50-60. PubMed ID: 8094569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteamine blocks somatostatin secretion without altering the course of insulin or glucagon release. A new model for the study of islet function.
    Sorenson RL; Grouse LH; Elde RP
    Diabetes; 1983 Apr; 32(4):377-9. PubMed ID: 6131850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the opioid receptor type mediating inhibition of rat gastric somatostatin secretion.
    McIntosh CH; Jia X; Kowk YN
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G922-7. PubMed ID: 1979718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-endorphin and islet hormone release in type-2 diabetes mellitus the effects of normoglycemia, enkephalin, naloxone and somatostatin.
    Giugliano D; Cozzolino D; Salvatore T; Ceriello A; Giunta R; Torella R; D'Onofrio F
    Diabete Metab; 1987; 13(6):618-24. PubMed ID: 2896134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of furosemide and indapamide upon pancreatic insulin and somatostatin secretion in vitro.
    Hermansen K; Schmitz O; Arnfred J; Mogensen CE
    Diabetes Res; 1986 May; 3(4):221-3. PubMed ID: 2874909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.